Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Abstract As the number of people living with type 2 diabetes (T2D) continues to rise, managing their complex needs presents an increasing challenge to physicians
GLP-1 Market Size and Forecast 2026 to 2035 The global GLP-1 market size accounted for USD 58.40 billion in 2025 and is predicted to increase from USD 66.46 billion in 2026 to approximately USD 212.73 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035
Current evidence suggests the weight loss associated with these medications, rather than the medications themselves, is likely the primary contributor
However, translating these findings into disease-modifying therapies requires standardization, the identification of robust biomarkers (e.g., SCFAs, LPS/LBP, bile acids, cytokine profiles), and the development of tailored clinical strategies based on disease stage and distinct microbiome-based patient subgroups
Huang, J
